Carbamazepine (Tegretol, Tegretol Chewtabs) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 29, 2026
Also sold as: Tegretol, Tegretol Chewtabs, Tegretol - Sus, Mazepine
Some Carbamazepine products are in shortage in Canada (3 of 20 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 21, 2026.
An anticonvulsant used to control seizures in epilepsy and to treat certain types of nerve pain.
Products affected
3 / 20
In shortage since
Oct 22, 2014
Est. full return
Aug 21, 2026
Reports on file
78
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TARO-CARBAMAZEPINE
100MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02367394 · since Jan 23, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
DIN 02261847 · ended Jul 2, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Carbamazepine is currently affected by 3 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC, SANDOZ CANADA INCORPORATED, BIOMED PHARMA.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; dormant. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Carbamazepine is classified under “ANTIEPILEPTICS” (ATC N03AF).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jul 31, 2026 → Aug 7, 2026
Jul 28, 2026
New report filed
Jul 14, 2026
Estimated end date pushed back : Jun 26, 2026 → Jul 31, 2026
Common questions
What is Carbamazepine used for?
An anticonvulsant used to control seizures in epilepsy and to treat certain types of nerve pain.
When will Carbamazepine be back in stock in Canada?
The latest manufacturer estimate is Aug 21, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Carbamazepine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antiepileptics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.